Advanced search
Publication Cover
The Physician and Sportsmedicine Volume 38, 2010 - Issue 2
Submit an article Journal homepage
32
Views
2
CrossRef citations to date
0
Altmetric
Practice Pearl

METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis

Rudy M. Haddad Baylor College of Medicine and Methodist DeBakey Heart and Vascular Center, Houston, TX
, MD &
Christie M. Ballantyne Baylor College of Medicine and Methodist DeBakey Heart and Vascular Center, Houston, TXCorrespondence[email protected]
, MD
Pages 180-182 | Published online: 13 Mar 2015

References

  • . Nissen SE, Tuzcu M, Schoenhagen P, et al; REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004;291(9):1071–1080
  • . Nissen SE, Nicholls SJ, Sipahi I, . ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of atherosclerosis: the Asteroid trial. JAMA. 2006;295(13):1556–1565
  • . Shepherd J, Cobbe SM, Ford I, . Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333(20):1301–1307
  • . Downs JR, Clearfield M, Weis S, . Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279(20):1615–1622
  • . Sever PS, Dahlöf B, Poulter NR, et al; ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo-Scandinavia Cardiac Outcome Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149–1158
  • . Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PW, Houston-Miller N. 34th Bethesda Conference: Task force #1—Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol. 2003;41(11):1863–1874
  • . Lavie CJ, Milani RV, Verma A, O'Keefe JH. C-reactive protein and cardiovascular disease—is it ready for primetime? Am J Med Sci. 2009;338(6):486–492
  • . Ridker PM, Danielson E, Fonseca FA, et al; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207
  • . Chambless LE, Heiss G, Folsom AR, . Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol. 1997;146(6):483–494
  • . Hodis HN, Mack WJ, LaBree L, . The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128(4):262–269
  • . Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial. Lancet. 2001;357(9256):577–581
  • . Crouse JR 3rd, Raichlen JS, Riley WA, et al; METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007;297(12):1344–1353
  • . Nambi V, Ballantyne CM, “Risky business”: ten years is not a lifetime. Circulation. 2009;119(3):362–364

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.